466 Studies Now Enrolling
A Translational and Neurocomputational Evaluation of a D1 Partial Agonist for Schizophrenia
An Evaluation of a Drug on Memory and Thinking in Patients with Early Episode Schizophrenia (TRANSCENDS)
| Sponsor: | National Institute of Mental Health NIMH |
| Enrolling: | Male and Female Patients |
| Clinic Visits: | 7 |
| IRB Number: | 7961 |
| U.S. Govt. ID: | NCT04457310 |
| Contact: | Moriah Dadson, MPH: 646-774-8496 / moriah.dadson@nyspi.columbia.edu |
Additional Study Information:
The purpose of this research study is to test the effectiveness of the study drug, PF-0641252, on regions of the brain that are responsible for thinking and memory in subjects with schizophrenia, schizoaffective disorder or related psychotic illnesses.
This study is closed
Do You Qualify?
| Are you willing and able to perform research procedures and a MRI? | Yes | No |
| Were you recently diagnosed with schizophrenia, schizoaffective disorder, or schizophreniform? | Yes | No |
| Have you been on a stable medication regimen (including no medications) for at least 3 weeks? | Yes | No |
| Are you predominantly right-handed? | Yes | No |